glp-1 pen injector components Pfizer Phase IIb Data Support Monthly Dosing for Obesity Designing GLP-1 delivery: structural perspectives

This is part of our commitment to providing research, trusted peptides, you dont have to just take our word for it

In ATTAIN-1, 3,127 overweight participants without diabetes were enrolled, while in ATTAIN-2, 1,613 overweight patients with type 2 diabetes were enrolled

Izadi R, Arkan E, Jalalvand AR, Akbari V

The phase 2 trial tested different starting dose strategies and found that slower titration reduced side effects but also delayed the onset of maximum weight loss

Nutrition becomes even more important for people who take GLP-1s, says Suzy Badaracco, a nutritionist, chef and CEO of marketing research firm Culinary Tides

Tirzepatide works most effectively when it is combined with a healthy diet and regular exercise